ProGenis Pharmaceuticals is a leading RNA biotechnology company, founded in Perth, Western Australia, in 2022. We are dedicated to developing next-generation, precision RNA medicines for the treatment of acquired and inherited rare diseases.

Co-founded by renowned experts Professor Marvin Caruthers and Professor Rakesh Veedu, our team is driven by a shared commitment to improving the health and wellbeing of individuals through groundbreaking therapeutics.